Recurrent/sustained elevated concentrations (i.e., being in the top quartile on ≥2 days) of MPO and IL-8 in the early epoch (i.e., days 1, 7, and 14) were associated with increased ROP risk. Here, MPO is linked to retinopathy of prematurity.